The Daily Scan

July 17, 2018

Last Updated: 11:35 AM EST

Litigation

  • Missouri-based Dr. Vidal Sheen pled guilty to obstructing an investigation by the FBI regarding whether he billed the Medicare program and private insurers for “face to face” office visits performed on dates when he was actually traveling outside of Missouri, and sometimes traveling outside of the United States. According to his plea agreement, Dr. Sheen operated a medical office in St. Louis County, Missouri.  At the medical office, Dr. Sheen created medical records using a template falsely recited patients’ symptoms and histories, and sometimes recorded vital signs (e.g. pulse rates) that did not change between patients’ visits. Moreover, from time to time, defendant traveled to various destinations, including Punta Cana in the Dominican Republic and Florida. For these time frames when Dr. Sheen was out of town, he created office notes with false entries reflecting that he had seen patients in his office, using his electronic signature. (Justice.gov)

Medicaid

  • More than 7,000 people on Arkansas’ Medicaid expansion didn’t meet a requirement that they report at least 80 hours of work in June and face the threat of losing their coverage if they fail to comply sometime before the end of this year, state officials said Friday. Arkansas’ requirement took effect last month. Participants in the program lose coverage if they don’t meet the work requirement for three months in a calendar year. The Department of Human Services said most of the more than 27,000 people on the expansion program who were notified they were subject to the new requirement were exempt or met the requirement. The federal government earlier this year approved the state’s plan to impose the work requirement as part of Arkansas’ expansion, which uses Medicaid funds to purchase private insurance for low-income residents. (APNews.com)

Regulation

  • Senator Tammy Baldwin (D-WI) wrote a letter yesterday to Ian Read, CEO of Pfizer, criticizing the company's recent rise in prescription prices: "Instead of playing games with the costs of prescription drugs that millions of Americans depend on, you should make a firm and clear commitment to permanently roll back prices." (Baldwin.Senate.gov)

 

  • Health and Human Services spokesperson Evelyn Stauffer issued the following statement yesterday on maximizing child welfare and meeting all court orders: "HHS has been working tirelessly with all relevant partners, including the court, to achieve two objectives related to the separated minors in our care: maximizing child welfare and meeting all court orders. The court has emphasized clear goals for the process of reunification: ensuring the safety and welfare of the children in question, confirming the parentage of the adults in question, and reunifying the parents and children as quickly as possible. HHS shares those goals. We have appreciated the opportunity to work with the court toward them, and will continue to do so. The department has been operating in good faith and earnestly trying to comply with court orders, including the rapidly approaching deadline for reunification." (HHS.gov

 

  • FDA Commissioner Scott Gottlieb, M.D. released a statement this morning on new efforts to empower consumers by advancing access to nonprescription drugs: "Currently, nonprescription drugs can be marketed under either of two regulatory pathways: the Over-the-Counter (OTC) Drug Review (OTC Monograph Process) or the New Drug Application (NDA) process, and there are different requirements under each system. Today’s new FDA draft guidance, Innovative Approaches for Nonprescription Drug Products, applies to drugs under the NDA process and is intended to extend that NDA pathway to include therapeutic indications that have not, historically, been available for use without a prescription." (FDA.gov)

 

 

 

Please reload

Our Recent Posts

The Weekly Scan

April 26, 2019

The Weekly Scan

April 12, 2019

The Weekly Scan

April 5, 2019

1/1
Please reload

Tags

Please reload

 

©2018 by FHAS Inc.

1 PPG Place, 31st Floor,

Pittsburgh, PA 15222